These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35484684)

  • 1. Interindividual Variability in Cytochrome P450 3A and 1A Activity Influences Sunitinib Metabolism and Bioactivation.
    Burnham EA; Abouda AA; Bissada JE; Nardone-White DT; Beers JL; Lee J; Vergne MJ; Jackson KD
    Chem Res Toxicol; 2022 May; 35(5):792-806. PubMed ID: 35484684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.
    Amaya GM; Durandis R; Bourgeois DS; Perkins JA; Abouda AA; Wines KJ; Mohamud M; Starks SA; Daniels RN; Jackson KD
    Chem Res Toxicol; 2018 Jul; 31(7):570-584. PubMed ID: 29847931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detoxication versus Bioactivation Pathways of Lapatinib In Vitro: UGT1A1 Catalyzes the Hepatic Glucuronidation of Debenzylated Lapatinib.
    Nardone-White DT; Bissada JE; Abouda AA; Jackson KD
    Drug Metab Dispos; 2021 Mar; 49(3):233-244. PubMed ID: 33376146
    [No Abstract]   [Full Text] [Related]  

  • 4. Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation.
    Bissada JE; Truong V; Abouda AA; Wines KJ; Crouch RD; Jackson KD
    Drug Metab Dispos; 2019 Nov; 47(11):1257-1269. PubMed ID: 31492693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib.
    Towles JK; Clark RN; Wahlin MD; Uttamsingh V; Rettie AE; Jackson KD
    Drug Metab Dispos; 2016 Oct; 44(10):1584-97. PubMed ID: 27450182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome p450-mediated metabolic activation of diosbulbin B.
    Lin D; Li C; Peng Y; Gao H; Zheng J
    Drug Metab Dispos; 2014 Oct; 42(10):1727-36. PubMed ID: 25024403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
    Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
    Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of oxymetazoline: evidence for bioactivation to a reactive metabolite.
    Mahajan MK; Uttamsingh V; Daniels JS; Gan LS; LeDuc BW; Williams DA
    Drug Metab Dispos; 2011 Apr; 39(4):693-702. PubMed ID: 21177487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative metabolism of aschantin in human and animal hepatocytes.
    Lee MS; Shim HJ; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
    Arch Pharm Res; 2024 Feb; 47(2):111-126. PubMed ID: 38182943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochromes P450 2C8 and 3A Catalyze the Metabolic Activation of the Tyrosine Kinase Inhibitor Masitinib.
    Latham BD; Oskin DS; Crouch RD; Vergne MJ; Jackson KD
    Chem Res Toxicol; 2022 Sep; 35(9):1467-1481. PubMed ID: 36048877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinib.
    Takakusa H; Wahlin MD; Zhao C; Hanson KL; New LS; Chan EC; Nelson SD
    Drug Metab Dispos; 2011 Jun; 39(6):1022-30. PubMed ID: 21363997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
    Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
    Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 mediated metabolic activation of chrysophanol.
    Sun Y; Xin X; Zhang K; Cui T; Peng Y; Zheng J
    Chem Biol Interact; 2018 Jun; 289():57-67. PubMed ID: 29698620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for cytochrome P450 3A4-mediated metabolic activation of SCO-267.
    Li C; Li X; Fan A; He N; Wu D; Yu H; Wang K; Jiao W; Zhao X
    Biopharm Drug Dispos; 2024 Feb; 45(1):30-42. PubMed ID: 38236698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of the active carfentanil metabolite, 4-Piperidinecarboxylic acid, 1-(2-hydroxy-2-phenylethyl)-4-[(1-oxopropyl)phenylamino]-, methyl ester in vitro.
    Kong L; Walz AJ
    Toxicol Lett; 2022 Aug; 367():32-39. PubMed ID: 35835351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism studies of nomifensine monooxygenation pathways: metabolite identification, reaction phenotyping, and bioactivation mechanism.
    Yu J; Brown DG; Burdette D
    Drug Metab Dispos; 2010 Oct; 38(10):1767-78. PubMed ID: 20595377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics.
    Ma B; Polsky-Fisher SL; Vickers S; Cui D; Rodrigues AD
    Drug Metab Dispos; 2007 Aug; 35(8):1301-7. PubMed ID: 17460031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
    Wen B; Chen Y; Fitch WL
    Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 3A4-Mediated Bioactivation and Its Role in Nomilin-Induced Hepatotoxicity.
    Zhang L; Liu Q; Pan Y; Qi X; Li Y; Chen C; Sun J
    Chem Res Toxicol; 2020 Aug; 33(8):2208-2217. PubMed ID: 32633501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel metabolites of buprenorphine detected in human liver microsomes and human urine.
    Chang Y; Moody DE; McCance-Katz EF
    Drug Metab Dispos; 2006 Mar; 34(3):440-8. PubMed ID: 16381669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.